Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147599 | SCV000195048 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000147599 | SCV000233092 | benign | not specified | 2014-12-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000147599 | SCV000311077 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000387787 | SCV000360299 | likely benign | De Lange syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000547458 | SCV000641112 | benign | Cornelia de Lange syndrome 3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312666 | SCV000846023 | likely benign | Inborn genetic diseases | 2019-04-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001574042 | SCV001901628 | benign | not provided | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000147599 | SCV001743541 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001574042 | SCV001800760 | likely benign | not provided | no assertion criteria provided | clinical testing |